Cargando…
Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs
PURPOSE: Triple negative (TN) breast cancers which lack expression of the estrogen (ER), progesterone (PR), and human epidermal growth factor 2 (HER2) receptors convey a poor prognosis due in part to a lack of targeted therapies. METHODS: To identify viable targets for the treatment of TN disease, w...
Autores principales: | Willis, Scooter, De, Pradip, Dey, Nandini, Long, Bradley, Young, Brandon, Sparano, Joseph A., Wang, Victoria, Davidson, Nancy E., Leyland-Jones, Brian R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436509/ https://www.ncbi.nlm.nih.gov/pubmed/26005638 http://dx.doi.org/10.1016/j.mgene.2015.04.002 |
Ejemplares similares
-
RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers
por: De, Pradip, et al.
Publicado: (2016) -
Differential Activation of Wnt-β-Catenin Pathway in Triple Negative Breast Cancer Increases MMP7 in a PTEN Dependent Manner
por: Dey, Nandini, et al.
Publicado: (2013) -
Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers
por: De, Pradip, et al.
Publicado: (2016) -
Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
por: Nandini, Dey, et al.
Publicado: (2021) -
Triple Fluorescence staining to Evaluate Mechanism-based Apoptosis following Chemotherapeutic and Targeted Anti-cancer Drugs in Live Tumor Cells
por: De, Pradip, et al.
Publicado: (2018)